Description
Aurogra (Sildenafil) 100 mg
Aurogra 100 mg is a sildenafil-containing medicine. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction in adult men. It is an on-demand treatment that supports erections during sexual stimulation, but it does not increase sexual desire.
Active Ingredient and Medicine Class
The verified active ingredient is sildenafil, a PDE5 inhibitor. This class works by enhancing the effect of nitric oxide in penile tissue and increasing blood flow during sexual arousal.
Established Medical Uses
Sildenafil is established for the treatment of erectile dysfunction. Regulatory labeling describes it as an oral therapy for men with ED, including ED of different causes. Its benefit is symptom relief rather than cure of the underlying condition.
How It Works
Sildenafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP, it helps relax smooth muscle in the corpus cavernosum and improves penile blood flow during sexual stimulation. This mechanism explains its use in erectile dysfunction.
Important Safety Information
Sildenafil is contraindicated with organic nitrates because of the risk of marked hypotension. Regulatory information also warns against use with nitric oxide donors and highlights clinically important interactions with alpha-blockers and other medicines that lower blood pressure. Caution is also advised in people with penile anatomical deformity or conditions that may predispose to priapism. PDE5 inhibitors have been associated with rare reports of sudden vision loss, sudden hearing loss, and prolonged erection.
Possible Side Effects
Common adverse effects include headache, flushing, dyspepsia, nasal congestion, and visual disturbance. Less common but important reactions include prolonged erection, priapism, sudden decrease or loss of vision, and sudden decrease or loss of hearing. Clinical reviews and prescribing information describe sildenafil as generally well tolerated, while emphasizing these clinically significant risks.
Scientific Evidence
Peer-reviewed reviews and meta-analyses show that sildenafil is more effective than placebo for improving erections and successful intercourse in men with erectile dysfunction. Safety reviews covering clinical trials and postmarketing data found that most adverse effects were mild to moderate, with serious events uncommon but important to recognize.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet, product labeling, or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / FDA: SILDENAFIL tablets, prescribing information. View source
- H. D. Langtry et al.: “Sildenafil: a review of its use in erectile dysfunction.” Drugs (1999). PubMed article
